Altimmune ALT
NASDAQ ALT
$1.93 -0.01 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Altimmune (ALT) Goodwill impairment charges (2017 - 2019)

Updated

Altimmune (ALT) posted Goodwill impairment charges of $490,676 for Q1 2018, down 94.7% from the prior quarter.

Analysis

Altimmune (ALT) Goodwill impairment charges (2017 - 2019) Analysis & Trends

For FY2017, Altimmune's Goodwill impairment charges came in at $35.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Altimmune 377.28 Mn -764.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 1.00 Mn
Dec 31, 2018 24.45 Mn
Mar 31, 2018 490,676.00
Dec 31, 2017 9.32 Mn
Sep 30, 2017 26.60 Mn
API Access

Altimmune Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ALT&period=max&api_key=YOUR_API_KEY